Strong investor response drives impressive listing on NSE and BSE today
Anthem Biosciences made a stellar debut on the stock market today, listing at ₹825 against an issue price of ₹705. The stock opened with a 17% premium and quickly gained momentum, reflecting strong investor confidence and high subscription demand.
Image source:- Mint
Anthem Biosciences Soars on Listing Day
Anthem Biosciences Limited officially entered the Indian stock market on July 21, 2025, and investors welcomed it with enthusiasm. The stock listed at ₹825 on both NSE and BSE, marking a robust 17% premium over the issue price of ₹705 per share. Within the first few hours of trade, the stock surged over 20%, crossing ₹850, signaling strong post-listing interest.
Subscription Numbers Back the Surge
The IPO received an overwhelming response, with the issue being oversubscribed nearly 70 times. Institutional investors and HNIs aggressively participated, which built strong anticipation around the listing. The strong GMP (grey market premium) of ₹120 before the debut also hinted at bullish sentiments.
Read more:-https://worldtrendnow.in/silver-pegasus-ipo-raises-115m-spac-investment-news/
What Drives Investor Interest?
Anthem Biosciences operates in the fast-growing biotech sector, offering contract research and manufacturing services (CRAMS). The company’s stable revenues, high-margin profile, and expansion plans have attracted long-term investors. Moreover, analysts noted the company’s global clientele and research pipeline as major valuation drivers.
Market Expert Insights
Market analysts have advised investors to hold the stock for long-term gains. While the listing premium is attractive, the company’s financials and sectoral potential offer more upside in the medium term. However, some experts have also suggested booking partial profits due to the steep listing gains.
What’s Next for Anthem?
Now that Anthem has entered the secondary market, investors will closely monitor its quarterly results and execution capabilities. The company aims to expand its R&D facilities and increase global client outreach using IPO proceeds.
For latest updates follow us on Instagram:-https://www.instagram.com/worldtrendnow.in
